Skip to main content Skip to main menu
UF Health University of Florida
Opavsky Lab Dept. of Anatomy & Cell Biology in the College of Medicine

Publications

  • Stribling D, Yi Lei, Guardia CM, Li L, Fields CJ, Nowialis P, Rene Opavsky, Renne R, Xie M. A non-canonical microRNA derived from the snaR-A non-coding RNA targets a metastasis inhibitor. RNA 078694.121Published in Advance April 1, 2021, doi:10.1261/rna.078694.121 | PubMed
  • Lopusna K*, Nowialis P*, Opavska J, Abraham A, Riva A, Haney SL, Opavsky R. (2021). Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice. J Biol Chem. 2021 Jan 12;:100285. doi: 10.1016/j.jbc.2021.100285 | PubMed (* equal contribution)
  • Lopusna K*, Nowialis P*, Opavska J, Abraham A, Riva A, Opavsky R. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. EBioMedicine. 2021 Jan;63:103191. doi: 10.1016/j.ebiom.2020.103191 | PubMed (* equal contribution)
  • Nowialis P*, Lopusna K*, Opavska J, Haney SL, Abraham A, Sheng P, Riva A, Natarajan A, Guryanova O, Simpson M, Hlady R, Xie M, Opavsky R. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions. Nat Commun. 2019 Sep 26;10(1):4374. doi: 10.1038/s41467-019-12355-7 | PubMed (* equal contribution)
  • Haney SL.*, Upchurch GM.*, Opavska J., Klinkebiel D., Hlady, R., Roy S., Dutta S., Datta K. Opavsky R (2016). Dnmt3a is a tumor suppressor gene in a prevention of CD8 positive T cell lymphomas. PLoS Genet., Sep 30;12(9):e1006334 | PubMed (* equal contribution)
  • Haney SL*, Upchurch GM*, Opavska J, Klinkebiel D, Appiah AK, Smith LM, Heavican TB, Iqbal J, Joshi S, Opavsky R (2016). Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Sci Rep. Sep 28;6:34222 | PubMed (* equal contribution)
  • Haney SL*, Hlady RA*, Opavska J, Klinkebiel D, Pirruccello SJ, Dutta S, Datta K, Simpson MA., Wu L., Opavsky R (2015). Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis. Oncogene advance online publication 2 February 2015 | PubMed (* equal contribution)
  • Haney SL, Upchurch GM, Opavska J, Klinkebiel D, Hlady RA, Suresh A, Pirruccello SJ, Shukla V, Lu R, Costinean S, Rizzino A, Karpf AR, Joshi S, Swanson P, Opavsky R (2016) Promoter hypomethylation and expression is conserved in mouse chronic lymphocytic leukemia induced by decreased or inactivated Dnmt3a. Cell Rep. 15; May 6, 1190–1201 | PubMed
  • Peters SL*, Hlady RA*, Opavska J, Klinkebiel D, Pirruccello SJ, Talmon GA, Sharp JG, Wu L, Jaenisch R, Simpson MA, Karpf AR, Opavsky R. (2014). Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis. Leukemia 28(5):1138-1142 | PubMed (* equal contribution)
  • Upchurch GM, Haney SL, Opavsky R. (2016). Aberrant promoter hypomethylation in CLL: does it matter for disease development? Front Oncol. Aug 11;6:182, Review | PubMed

(lab members highlighted in bold)

Visit PubMed for a full list of references